Study | Period covered | Study type | Age (years) | No.of cases | OR (95 % CI) |
---|---|---|---|---|---|
Glioma | |||||
2000–2004 | Case–control | 30–69 | 322 | 1.22 (0.63–2.37) | |
2000–2004 | Case–control | 30–69 | 1078 | glioma 0.81 (0.70–0.94) | |
1990–2007 | cohort | ≥30 | 356 | 1.04 (0.85 - 1.26) in men and 1.04 (0.56 -1.95) in women | |
1974–2003 | cohort | 20–79 | 5390 | 1.05 (0.98-1.08) among men and 1.02 (1.01-1.05) among women | |
2000–2003 | Case–control | 30–69 | 257 | 0.98 (0.74-1.29) ≥10 years, 2.20, (0.94-5.11) | |
1997–2003 and 2007–2009 | case-case analyses | 18–75 | 1678 | >20 years 1.7 (1.2–2.3); astrocytoma grade IV Mobile phone use 2.0 (1.4-2.9); cordless phone use 3.4 (1.04-11) | |
1997–2003 | Case–control | 18–75 | 905 | >10 years, grade I-II 1.6 (0.6-4.1) grade III-IV 2.7 (1.8-4.2) | |
1999–2005 and again in 2009 | cohort | middle-aged women | 571 | 0.78, (0.55–1.10), | |
2000–2004 | Case–control | 30–59 | 553 | 0.93 (0.73 to 1.18) | |
Meningioma | |||||
2000–2004 | Case–control | 30–69 | 322 | 0.70 (0.42–1.16) | |
2000–2004 | Case–control | 30–69 | 1147 | 0.79; (0.68–0.91) | |
1990–2007 | cohort | ≥30 | 80 | ≥10 years, 0.90 (0.57 to 1.42) in men and 0.93 (0.46- 1.87) in women | |
1974–2003 | cohort | 20–79 | 3175 | 1.08 (0.96-1.13) among men, and 1.38 (1.32-1.44) among women | |
2000–2003 | Case–control | 30–69 | 381 | 0.84 (0.62-1.13) ≥10 years, 1.09 (0.35-3.37) | |
1999–2005 and again in 2009. | cohort | middle-aged women | 251 | 0.78, (0.55–1.10) | |
2000–2004 | Case–control | 30–59 | 676 | 0.80 (0.66 to 0.96) | |
1997–2003 | Case–control | 18–75 | 759 | 1.3, (0.5-3.2) | |
Acoustic Neuroma | |||||
1999–2005 and again in 2009 | cohort | middle-aged women | 96 | 2.46 (1.07–5.64) | |
Pituitary adenoma | |||||
2000–2004 | Case–control | 30–69 | 110 | 0.90 (0.50–1.61) |